| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr21:39811200-39847400 |
Weak transcription |
Right Ventricle |
heart
|
| 2 |
chr21:39843400-39855200 |
Weak transcription |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
| 3 |
chr21:39843400-39858200 |
Weak transcription |
Esophagus |
oesophagus
|
| 4 |
chr21:39844800-39847600 |
Weak transcription |
HUES48 Cell Line |
embryonic stem cell
|
| 5 |
chr21:39845000-39847400 |
Weak transcription |
Left Ventricle |
heart
|
| 6 |
chr21:39845000-39848200 |
Weak transcription |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
| 7 |
chr21:39845000-39849000 |
Weak transcription |
Right Atrium |
heart
|
| 8 |
chr21:39845200-39848000 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
| 9 |
chr21:39845200-39848000 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
| 10 |
chr21:39845800-39847400 |
Bivalent Enhancer |
Skeletal Muscle Male |
skeletal muscle
|
| 11 |
chr21:39845800-39848200 |
Enhancers |
Fetal Thymus |
thymus
|
| 12 |
chr21:39846000-39847800 |
Enhancers |
HMEC |
breast
|
| 13 |
chr21:39846200-39847800 |
Enhancers |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
| 14 |
chr21:39846200-39848000 |
Enhancers |
Spleen |
Spleen
|
| 15 |
chr21:39846400-39847400 |
Weak transcription |
H1 Cell Line |
embryonic stem cell
|
| 16 |
chr21:39846400-39847400 |
Weak transcription |
HUES6 Cell Line |
embryonic stem cell
|
| 17 |
chr21:39846400-39847400 |
Weak transcription |
Aorta |
Aorta
|
| 18 |
chr21:39846400-39847600 |
Weak transcription |
Fetal Heart |
heart
|
| 19 |
chr21:39846400-39847800 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
| 20 |
chr21:39846400-39849000 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
| 21 |
chr21:39846400-39855600 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
| 22 |
chr21:39846400-39855800 |
Weak transcription |
Breast Myoepithelial Primary Cells |
Breast
|
| 23 |
chr21:39846600-39847600 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
| 24 |
chr21:39846600-39847600 |
Enhancers |
HUVEC |
blood vessel
|
| 25 |
chr21:39846600-39849400 |
Weak transcription |
Osteobl |
bone
|
| 26 |
chr21:39846800-39847600 |
Enhancers |
Adipose Nuclei |
Adipose
|
| 27 |
chr21:39846800-39851400 |
Enhancers |
Thymus |
Thymus
|
| 28 |
chr21:39847000-39847400 |
Enhancers |
ES-WA7 Cell Line |
embryonic stem cell
|
| 29 |
chr21:39847000-39847400 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 30 |
chr21:39847000-39847400 |
Bivalent Enhancer |
Skeletal Muscle Female |
skeletal muscle
|
| 31 |
chr21:39847000-39847800 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 32 |
chr21:39847000-39847800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
| 33 |
chr21:39847000-39848200 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
| 34 |
chr21:39847000-39848800 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
| 35 |
chr21:39847000-39849600 |
Flanking Active TSS |
Primary hematopoietic stem cells |
blood
|
| 36 |
chr21:39847000-39850800 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 37 |
chr21:39847200-39847400 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
| 38 |
chr21:39847200-39847400 |
Bivalent Enhancer |
Primary B cells from cord blood |
blood
|
| 39 |
chr21:39847200-39847800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
| 40 |
chr21:39847200-39847800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
| 41 |
chr21:39847200-39847800 |
Enhancers |
NHEK |
skin
|
| 42 |
chr21:39847200-39850600 |
Flanking Active TSS |
Primary hematopoietic stem cells short term culture |
blood
|
| 43 |
chr21:39847200-39850800 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
